Company profile: HistoCyte Laboratories
1.1 - Company Overview
Company description
- Provider of cell line controls and services for immunohistochemistry and in situ hybridization in cancer diagnosis, offering pre-cut slides and cell microarray blocks, dynamic range and standard controls, custom cell line development, biomarker characterization and assessment, and proof-of-concept and feasibility studies to improve assay confidence and assess assay quality.
Products and services
- Dynamic Range Controls: These controls offer a semi-quantitative means to assess assay quality by demonstrating the relative sensitivity of tests across a range of biomarker expressions
- Cell Line Controls: HistoCyte Laboratories delivers IHC/ISH-compatible cell line controls as pre-cut slides or cell microarray blocks, architected to improve assay confidence for immunohistochemistry and in situ hybridization applications
- Standard Controls: Standard controls furnish a qualitative means to verify assay functionality, featuring positive and negative expressions for various biomarkers within immunohistochemical cancer testing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to HistoCyte Laboratories
ProciseDx
HQ: United States
Website
- Description: Provider of point-of-care diagnostic solutions for physician offices, retail clinics, and urgent care, delivering rapid, lab-quality results. Offerings include tests for infliximab (Procise IFX), adalimumab (Procise ADL), C-reactive protein (Procise CRP), fecal calprotectin (Procise FCP), and the ProciseDx Instrument for quantitative immunoassays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProciseDx company profile →
NanoRepro
HQ: Germany
Website
- Description: Provider of rapid medical self-tests and diagnostics, developing, manufacturing, and distributing products for domestic and clinical use across women's health, fertility, prevention, family planning, health care, allergies, and food intolerance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoRepro company profile →
NIMGenetics
HQ: Spain
Website
- Description: Provider of analytical diagnostic services with a Genetics unit authorized by the Consejería de Sanidad de la Comunidad de Madrid, delivered by a medically and scientifically accredited team by the Asociación Española de Genética Humana, specialized in the development and application of high genomic systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NIMGenetics company profile →
Gold Standard Diagnostics
HQ: United States
Website
- Description: Provider of products, services, and consulting for the diagnostic and medical communities, partnering with reagent and equipment manufacturers worldwide to deliver innovative, cost-effective diagnostic solutions for clinical and hospital laboratories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gold Standard Diagnostics company profile →
Navigenics
HQ: United States
Website
- Description: Provider of personal genomics services using genetic testing to assess individual risk for health conditions, educating and empowering individuals and their physicians with knowledge of genetic predispositions to motivate prevention, enable earlier diagnosis, and support appropriate disease management to lessen disease impact.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Navigenics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HistoCyte Laboratories
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to HistoCyte Laboratories
2.2 - Growth funds investing in similar companies to HistoCyte Laboratories
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HistoCyte Laboratories
4.2 - Public trading comparable groups for HistoCyte Laboratories
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →